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Edited by Robert BaroukiAbstract Liver key genes for carbohydrate and lipid homeosta-
sis are regulated by insulin and glucose. The sterol regulatory-
element binding protein-1c (SREBP-1c) has emerged as a
mediator of insulin eﬀects on gene transcription, particularly
on glucokinase (GK). In this paper, we show that despite stimu-
lation of GK promoter transcription by overexpression of mature
SREBP-1c, insulin induced GK transcription at least 4 h ahead
of accumulation of mature SREBP-1c in the nucleus. Impor-
tantly, the knockdown of SREBP-1 mRNA using a RNA-inter-
ference technique reduced the level of nuclear SREBP-1 protein,
diminished fatty acid synthase mRNA level, but did not aﬀect
GK and L-pyruvate kinase mRNA levels. We concluded that
SREBP-1 is unlikely to be the mediator of the early insulin eﬀect
on GK gene transcription.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Transcriptional activation of liver glycolytic and lipogenic
genes, a relatively delayed phenomenon, requires the presence
of both glucose and insulin, neither of which being active alone
[1,2]. In contrast, stimulation of glucokinase (GK) gene, cod-
ing for the ﬁrst enzyme involved in glucose metabolism, is a ra-
pid strictly insulin-dependent and glucose-independent process
[3,4]. When GK is overexpressed either in hepatoma cells [5] or
in liver of diabetic mice [6], the transcriptional activation of
glycolytic and lipogenic genes becomes insulin-independent
and glucose-dependent. Similarly, in absence of GK in hepatic
GK-KO mice, glycolytic and lipogenic genes are not induced
after refeeding a high carbohydrate diet [7]. Therefore, insulin
induction of GK gene expression is the key step to subsequent
activation of glycolytic and lipogenic gene expression by glu-Abbreviations: GK, glucokinase; L-PK, L-pyruvate kinase; FAS, fatty
acid synthase; PEPCK, phosphoenolpyruvate kinase; SREBP, sterol
regulatory element binding protein; CAT, chloramphenicol acetyl-
transferase; siRNA, small interfering RNA; SRE, sterol regulatory
element; ChoRE, carbohydrate responsive element; ChREBP, carbo-
hydrate responsive element binding protein
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insulin regulates GK gene expression are still controversial
and the cis-acting elements mediating insulin eﬀects remain un-
known. The transcription factor sterol regulatory-element
binding protein-1c (SREBP-1c), whose transcription is also
insulin-dependent, was pointed out as the main mediator of
insulin eﬀect on GK gene expression [8,9], but other studies
failed to conﬁrm this ﬁnding [10,11]. Therefore, whether or
not SREBP1-c mediates the action of insulin on GK gene
expression is still a controversial issue.
Owing to the central role of insulin in the control of liver
metabolism, and of GK in glucose metabolism, the goal of this
study was to reinvestigate the role of SREBP-1c in mediating
insulin eﬀect upon GK gene expression. For this purpose, we
studied in primary cultured hepatocytes the kinetics of insulin
upregulation of GK gene transcription as well as the level of
transcriptionally active SREBP-1 protein in the nucleus. Fur-
ther, SREBP-1 knockdown by small interfering RNAs (siR-
NAs) resulted in an impaired induction of fatty acid
synthase (FAS) gene in response to glucose and insulin, but
did not prevent the induction of GK and L-pyruvate kinase
(L-PK) genes. We clearly demonstrated that early insulin stim-
ulation of GK gene was SREBP-1-independent.2. Materials and methods
2.1. Primary hepatocyte culture
Hepatocytes were isolated from liver of 8-week-old male Wistar rats
after perfusion with collagenase. Hepatocytes were seeded at a density
of 3.5 · 106 cells per dish (20 cm2) in M199 medium with Earl’s salts
(Invitrogen) supplemented with 100 U/ml penicillin, 100 lg/ml strepto-
mycin, 0.1% (w/v) BSA and 2% (v/v) Ultroser G (BioSepra). After a
4 h-incubation at 37 C under 5% (v/v) CO2, the cells were washed with
PBS and switched for 16 h to a BSA–Ultroser-free medium. The med-
ium was then supplemented with 1 lM dexamethasone, in the absence
or presence of insulin and/or glucose as indicated in the ﬁgure legends.
2.2. Plasmid construction and transient transfection
GK promoter construct: The mouse GK–chloramphenicol acetyl-
transferase (CAT) plasmid is the PeCAT vector [12] in which the frag-
ment (960 to +19 bp) of the mouse liver GK promoter was
subcloned, along with two fragments (+145 to +272 and +4035 to
+4120) corresponding to the splice sequence in 5 0 and 3 0 of the ﬁrst in-
tron, respectively. These splice fragments were obtained by PCR using
added restriction sites (underlined): For the 3 0 splice: 5 0-TATGG-
TACCCTTGGTGTGTGGTGGCTT-3 0 and 5 0-TTAGAGCTCTGC-
CAGGATCTGCTCTACC-30. For the 5 0 splice: 5 0-TTACCTTGGAG
CCCAGTCGTTGACTCT-3 0 and 5 0-TTCGGATCCTACAGGATC-
GCACTCA-3 0. The PCR product for the 3 0 splice fragment wasblished by Elsevier B.V. All rights reserved.
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the same enzymes. The PCR product for the 5 0 splice and the promoter
fragments were ﬁrst digested by Sty1 and then ligated together. The
resulting fragment was digested by HindIII and BamH1 and subcloned
in the above-described plasmid digested with the same enzymes. All
fragments generated by PCR were sequenced.
SREBP-1c expression plasmid: SREBP-1c plasmid was the pSV-
Sport1-ADD1 (403) coding for the nuclear transcription factor [13]
(gift of Dr. B.M. Spiegelman, Harvard Medical School, Boston, MA).
Transient transfections: Transfections were carried out as previously
described [14]. In each experiment, 7.5 lg of the CAT plasmid and
2.5 lg of the luciferase plasmid were cotransfected. The luciferase stan-
dardization pRSV plasmid was used to monitor variations in transfec-
tion eﬃciency. The CAT assay and luciferase assay were performed as
previously described [12].
2.3. RNA isolation and Northern-blot analysis
Total RNA extraction from cultured hepatocytes was performed
using the RNAzol B reagent (Q Biogene) according to the manufac-
turer’s instructions. 15 lg aliquots of total RNA were electrophoreti-
cally separated in denaturating formaldehyde agarose gels and
transferred to Hybond N+ membranes (Amersham). The cDNA
probes were labeled with (a-32P) dATP using random prime labeling
(Amersham-Pharmacia Biotech). The membranes were hybridized
with the indicated 32P-labeled probe (106 cpm/ml) at 42 C overnight.
The GK, L-PK, phosphoenolpyruvate kinase (PEPCK), FAS and
SREBP-1 probes were obtained as previously described [15]. Northern
blots were hybridized with a 32P-labeled ribosomal 18S probe to verify
that equivalent amounts of total RNA were loaded in each lane.
2.4. Immunoblot analysis
Nuclear extracts and membrane fractions were prepared from cul-
tured hepatocytes using the NE-PER Nuclear and Cytoplasmic
Extraction Reagents Kit (Pierce) according to the instructions pro-
vided by the manufacturer. Protein concentration was determined
using the Bradford method (Bio-Rad).
Proteins (35 lg) were separated by SDS–PAGE (7% polyacrylamide
gel) and transferred to a nitrocellulose membrane (Bio-Rad). Immuno-
blot analysis was performed using a monoclonal anti-SREBP-1 anti-
body (clone 2A4 from NeoMarkers), a Lamin A/C antibody from
Cell Signalling and the Enhanced Chemiluminescence System (Super-
signal, Pierce).
2.5. Design, synthesis and transfection of siRNA
A target sequence in the rat SREBP-1 mRNA (GenBank Accession
No. L16995) [13] was identiﬁed following the principles described by
Elbashir et al. [16] as previously described [17]. Primary rat hepato-
cytes were cultured in antibiotic-free medium the day before transfec-
tion. Cells transfection was conducted using Lipofectamine 2000
according to the supplier’s instruction (Invitrogen). On day 1, hepato-
cytes were transfected with 200 pmol siRNA per 20-cm2 dish. On day
2, the medium was supplemented with 100 nM insulin and 25 mM glu-
cose. Twenty-four hours later, cells were harvested and either RNA or
proteins were prepared.Fig. 1. Regulation of GK gene transcription by SREBP-1c and insulin
in cultured rat hepatocytes. (A) Primary hepatocytes cultured for 16 h
in the presence of 5 mM glucose without insulin were then transfected
with 7.5 lg of CAT–GK fusion gene, 2.5 lg of the reference plasmid
RSV luciferase and the indicated amount of expression vector for
mature SREBP-1c. Cells were cultured in medium containing 5 mM
glucose, in the absence (h) or presence (d) of 100 nM insulin. CAT
activity was normalized according to transfection eﬃciency by
measuring the luciferase activity. Values are means of four separate
experiments performed in duplicate. (B) Time course of GK and
SREBP-1 mRNA accumulation in hepatocytes cultured in the presence
of 5 mM glucose and 100 nM insulin. Total mRNA (15 lg) were
subjected to electrophoresis and blot hybridization with the indicated
32P-labeled cDNA probe. (C) Time-course appearance of SREBP-1
precursor (P) and mature (M) proteins. Membrane pellet and nuclear
extract (35 lg protein) were subjected to SDS/PAGE and analyzed by
immunoblotting using an antibody against the precursor and mature
forms of SREBP-1. Lamin A/C was used as control for the nuclear
extract. The blots are representative of three independent experiments.3. Results
3.1. Regulation of GK gene transcription by SREBP-1c and
insulin in cultured rat hepatocytes
Two potential binding sites for the transcription factor
SREBP were identiﬁed, by computer analysis, in the mouse
GK promoter (113 to 106 and 65 to 55). To test
SREBP-1c eﬀect upon GK fusion gene expression we used pri-
mary cultured rat hepatocytes. We transiently transfected cells
with a GK–CAT fusion gene, containing the promoter se-
quence located between 960 and +19, and either a control
expression vector or the same vector encoding nSREBP-1c
[13]. The cells were cultured in the absence or presence of insu-
lin. When SREBP-1c was overexpressed, GK–CAT fusiongene expression was induced in a concentration-dependent
manner (Fig. 1). At the maximum amount tested (1.25 lg),
the control expression vector had no eﬀect (data not shown)
whereas the constitutively active SREBP1-c stimulated 2.5-fold
the GK promoter activity. Strikingly, insulin treatment failed
to induce basal GK–CAT fusion gene expression (Fig. 1A
point 0 lg). These data indicated that the SREBP binding sites
may well be functional but requestioned the role of SREBP-1c
as a major mediator of insulin action on GK gene expression.
To ascertain these results, the well-established eﬀects of insu-
lin on endogenous GK mRNA level [3,18] were measured, in
the same pool of cultured hepatocytes but untransfected. We
observed the expected rapid (2 h) time-dependent accumula-
tion of GK mRNA in the presence of insulin and low glucose
concentration (5 mM) (Fig. 1B), indicating that insulin signaling
Fig. 3. Eﬀect of SREBP-1 knockdown by RNA interference (siRNA)
on glycolytic and lipogenic gene expression in rat hepatocytes. Twelve
hours after transfection with a SREBP-1 siRNA duplex as described in
Section 2, hepatocytes were cultured for 24 h in the presence of 100 nM
insulin and 25 mM glucose. Total mRNA, membrane and nuclear
extracts were then prepared. (A) Western blotting was performed to
detect SREBP-1 precursor (P) and mature (M) proteins. Lamin A/C
was used as control for the nuclear extract. (B) Total RNA (15 lg)
were subjected to blot hybridization with indicated 32P-labeled cDNA
probes Northern blots were scanned and quantiﬁed. Each value
represents the amount of mRNA relative to that in the untransfected
cells which is arbitrarily set to 100. Values represent means ± S.E. of
data from three independent experiments.
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SREBP-1 mRNA accumulated in parallel with GK mRNA
(Fig. 1B). We next measured endogenous SREBP-1 protein
levels both in membrane and nuclear extracts. SREBP-1
precursor amount reﬂected the insulin-induced upregulation
of SREBP-1 mRNA (Fig. 1C). In marked contrast, mature
form of SREBP-1 protein, which serves as an active transcrip-
tion factor, was undetectable during the ﬁrst 6-h incubation
with insulin and was highest after 24 h (Fig. 1C). If SREBP-1
was the insulin-dependent transcription factor controlling
GK gene transcription, we would expect to detect SREBP-1
protein in nuclear extracts ahead to accumulation of GK
mRNA. Altogether, these observations argued against
SREBP-1 being the prime mediator of insulin eﬀect upon GK
gene transcription.
3.2. Glycolytic and lipogenic gene expression in hepatocytes
In order to check the functionality of metabolic responses in
cultured hepatocytes, we measured mRNA levels of the key
glycolytic (L-PK), lipogenic (FAS) genes known to be induced
by insulin and/or glucose [19] and gluconeogenic (PEPCK)
gene known to be repressed by insulin. Hepatocytes were incu-
bated for 16 h in the presence of low glucose (5 mM) and no
insulin. Thereafter, the cells were incubated for 24 h with high
glucose (25 mM) and insulin (100 nM). As expected, Fig. 2
shows an increase in GK and SREBP-1 mRNAs within 2 h fol-
lowed by L-PK and FAS mRNAs at 24 h as well as the marked
suppression of PEPCK mRNA after 2 h. These results demon-
strated that insulin and glucose signalings were maintained in
cultured hepatocytes.
3.3. Silencing of SREBP-1 in hepatocytes
To test the direct control of GK gene transcription by
SREBP-1 in another way, hepatocytes were transfected with
a SREBP-1 siRNA duplex and then maintained for 24 h in
the presence of insulin and high glucose concentration to in-
duce transcription of control genes such as FAS. Both
SREBP-1 mRNA and nuclear active SREBP-1 protein were
severely reduced in transfected cells (Fig. 3A and B), indicatingFig. 2. Glycolytic and lipogenic genes induction by glucose and
insulin. Hepatocytes cultured 16 h in the presence of 5 mM glucose
without insulin (time 0) were maintained for a further 24 h in the
presence of 25 mM glucose and 100 nM insulin. Total RNA (15 lg)
were subjected to blot hybridization with the indicated 32P-labeled
cDNA probe. The blots are representative of three independent
experiments.an eﬃcient knockdown of SREBP-1 expression. Under these
conditions, we observed a marked impairment of FAS mRNA
accumulation, but no change in L-PK and GK mRNAs
(Fig. 3B). These results conﬁrmed SREBP-1 as being a media-
tor of insulin eﬀects upon FAS gene transcription, but deﬁni-
tively ruled out its role in controlling GK and L-PK gene
expression.4. Discussion
The SREBPs are a family of three nuclear transcription fac-
tors encoded by two genes. SREBP-1a and SREBP-1c derive
from the same gene, and both appear to regulate lipogenic
gene transcription [20]. Despite being a weak activator [21],
SREBP-1c is the dominant isoform in liver where its regulation
is insulin-dependent [22]. The purpose of the present work was
to clarify the involvement of SREBP-1 in insulin-mediated
induction of GK.
In agreement with studies in this ﬁeld [8], we have demon-
strated that, when ectopically overexpressed in isolated hepa-
tocytes, SREBP-1c enhanced the transcription of GK
promoter in a dose-dependent manner. Although a role for
SREBP in controlling GK transcription cannot be ruled out,
the striking observation that the basal activity of GK–CAT fu-
sion gene was insensitive to insulin put into question the role of
SREBP in mediating insulin eﬀects. Indeed, its involvement in
insulin early eﬀect seems rather unlikely since, in the same cul-
ture of hepatocytes, the accumulation of mature SREBP-1
protein was not seen in the nucleus 2 h after insulin addition,
whereas GK gene was already actively transcribed. These data
indicated that factor(s) other than SREBP-1 could be essential
for induction of GK gene transcription following insulin chal-
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the binding of SREBP-1 to GK promoter in liver of rats refed
a high carbohydrate/fat-free diet for 24 h. Therefore, SREBP
could play a critical role in sustaining long term GK gene tran-
scription in the presence of insulin.
Finally, SREBP-1 knockdown, using the RNA interference
technique, severely reduced the eﬀects of insulin and 25 mM
glucose on FAS gene expression, but not on GK and L-PK
gene expression. These results correlated with the observed re-
sponse of GK to carbohydrate refeeding in SREBP-1c knock-
out mice [23]. Considered altogether, these data deﬁnitely
established that SREBP-1c is not the early mediator of insulin
eﬀect upon GK gene transcription. The decrease, rather than
the extinction of FAS gene transcription upon SREBP-1
knockdown, is in line with previous studies suggesting that
SREBP-1 works in concert with other factor(s) for full induc-
tion of FAS gene transcription [24–26]. By contrast, L-PK
gene transcription has been demonstrated to be SREBP-1-
independent [27,28]. A glucose responsive element (ChoRE)
was deﬁned within the L-PK and FAS promoters [29–31]
and a transcription factor, ChRE-binding protein (ChREBP),
recognizing this sequence was identiﬁed [32,33]. Its functional-
ity was conﬁrmed by transfection experiments [34], RNA inter-
ference [7] and ﬁnally by gene disruption [35].
In conclusion, by performing time-course studies and knock-
down of SREBP-1 in cultured rat hepatocytes, we demon-
strated that the induction of GK gene expression by insulin
could occur in the absence of mature SREBP-1 in the nucleus.
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